Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results
Omnicell delivers strong fourth quarter financial results. Results exceed previously issued full year guidance for bookings, total revenues, and non-GAAP EBITDA. FORT WORTH, Texas ...
Eli Lilly Adjusted Profit Tops Estimates as Weight-Loss Drug Sales Fall Short
Eli Lilly shares rose Thursday after the drugmaker's adjusted profit came in above estimates, offsetting weaker-than-expected revenue.
Carlsberg Beats Profit Expectations, Warns of Slower Growth Ahead
The brewer expects slower growth due to the loss of the San Miguel brand license in the U.K.
Lilly’s Mounjaro and Zepbound contribute to big revenue boost, drugmaker says
Eli Lilly & Co. said its Type-2 Diabetes drug Mounjaro and weight-loss/diabetes medicine Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion.
Nordecon: 2024 IV quarter and 12 months consolidated interim report (unaudited)
The year 2024 was successful for the Nordecon Group. Profitability improved significantly, and revenue increased. The general contracting market remains highly competitive, and developers' confidence ...
EPLUS INC.: ePlus Reports Third Quarter and First Nine Months Results
HERNDON, Va., Feb. 5, 2025 /PRNewswire/ -- ePlus inc. (NASDAQ: PLUS), a leading provider of technology and financing solutions, today announced financial results for the three months and nine months ...